nasdaq.com ›
post › 78693398805420932532
August 14, 2025
(RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold b…
nasdaq.com ›
post › 46941741382281253217
May 16, 2025
Solventum has outperformed the broader market over the past year, yet analysts remain cautious about the stock’s prospects.
nasdaq.com ›
post › 44226731859685696778
April 28, 2025
Solventum is expected to unveil its first quarter results in the upcoming month, and analysts predict its bottom line to suffer in double digits.
nasdaq.com ›
post › 61638025363593785671
April 2, 2025
Despite outpacing the healthcare sector over the past year, analysts remain cautious about the stock’s prospects.
nasdaq.com ›
post › 60423363706912749562
February 28, 2025
Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at $1.41 against an anticipated $1.31 and revenue of $2.074 billion…
nasdaq.com ›
post › 85926342143151273727
February 17, 2025
Although Solventum has outperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's growth potential.
